Table of Contents
ISRN Neurology
Volume 2013 (2013), Article ID 128591, 6 pages
http://dx.doi.org/10.1155/2013/128591
Clinical Study

Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study

1Cell Therapy Center, 323 Hospital of Chinese People's Liberation Army, Xi'an 710054, China
2Alliancells Institute of Stem Cells and Translational Regenerative Medicine & Alliancells Bioscience Co., Ltd., Tianjin 300381, China
3Zhongyuan Union Stem Cell Bioengineering Co., Ltd., Tianjin 300050, China
4Beijing Alliancells-PuRui Bioscience Co., Ltd., Beijing 100052, China
5Department of Cell Biology, Oklahoma State University, Tulsa, OK 74106, USA
6Harold Hamm Diabetes Center and Section of Endocrinology and Diabetes in the Department of Internal Medicine, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Received 8 July 2013; Accepted 27 August 2013

Academic Editors: J. Chen and K. R. Pennypacker

Copyright © 2013 Liming Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Liming Wang, Haijie Ji, Ming Li, et al., “Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study,” ISRN Neurology, vol. 2013, Article ID 128591, 6 pages, 2013. doi:10.1155/2013/128591